Epitalon

Epitalon is the short peptide the longevity world keeps coming back to. Modelled on Epithalamin — a regulatory peptide the pineal gland naturally produces — this stable tetrapeptide (Ala-Glu-Asp-Gly) was developed at the St. Petersburg Institute of Bioregulation and Gerontology and has been explored for decades as a bioregulator of the pineal-neuroendocrine axis. Researchers prize it for its proposed activation of telomerase, the enzyme that extends telomeric DNA, alongside reported effects on circadian melatonin rhythms and antioxidant defence in aging models. Every 10 mg vial is research-grade material, third-party verified to 99.4% purity, and lyophilised for a clean, consistent reconstitution. Supplied strictly for research purposes only.

• Proposed activation of telomerase to elongate telomeres in somatic cell research
• Normalises pineal function and restores circadian melatonin rhythms in animal models
• Demonstrates antioxidant activity, reducing lipid peroxidation in aging tissue
• Oncostatic effects observed in carcinogen-treated aging animal populations
• Supports neuroendocrine balance across the pineal-hypothalamic axis
• Improves markers of immune function in aging research subjects
• Short, stable tetrapeptide widely used as a longevity research model

Research Administration

Subcutaneous injection, 5–10 mg daily for 10–20 day cycles in research protocols

For research purposes only. Not for human consumption.

• Store at −20°C in a dry, sealed environment
• Reconstitute with bacteriostatic water; use within 30 days at 4°C
• Avoid repeated freeze-thaw cycles
• Supplied for research purposes only — not for human or veterinary use